利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

4 条记录 (耗时 0.012 秒)

    Blood group antigen panel
    4.
    发明授权
    Blood group antigen panel 失效
    血型抗原组

    公开(公告)号：US5168043A

    公开(公告)日：1992-12-01

    申请号：US330591

    申请日：1989-03-28

    申请人： Carlos Cordon-Cardo ,  Kenneth O. Lloyd ,  Connie L. Finstad ,  Lloyd J. Old ,  Mryon R. Melamed ,  Joel Sheinfeld

    发明人： Carlos Cordon-Cardo ,  Kenneth O. Lloyd ,  Connie L. Finstad ,  Lloyd J. Old ,  Mryon R. Melamed ,  Joel Sheinfeld

    IPC分类号： C07K16/30 ,  C07K16/34

    CPC分类号： C07K16/30 ,  C07K16/34 ,  Y10S435/96 ,  Y10S436/811 ,  Y10S436/813

    摘要： The subject invention describes a method of determining the secretor status of an individual which comprises obtaining a sample of a biological fluid from the individual and determining whether the sample includes the Lewis.sup.a or Lewis.sup.b antigens, the presence of the Lewis.sup.a antigen in the sample indicating that the individual is a nonsecretor, the presence of the Lewis.sup.b antigen in the sample indicating that the individual is a secretor, and the presence of neither antigen indicating the secretor status of the individual is inconclusive. The invention also provides a method of further determining the secretor status of an individual of having an inconclusive secretor status which comprises determining whether the biological fluid sample from the individual includes A, B or precursor type 1 chain antigens, the presence of any such antigens in the sample indicating that the individual is a secretor, the lack of any such antigens in the sample indicating that the individual is a nonsecretor. The invention provides a method of determining whether a human female subject is susceptible to urogenital infection which comprises determining whether the subject is a secretor according to the hereinabove-described methods, a secretor being susceptible to such an infection. The present application also provides a method of disstinguishing urothelial carcinoma from normal tissue, and identifying human germ cell tumor as seminoma or nonseminoma. Finally, the invention provides a panel comprising some or all of the monoclonal antibodies H 29-36 (ATCC No. HB 8248), S8 (ATCC No. HB 9036), T 174 (ATCC No. HB 8242), T 218 (ATCC No. HB 8249), P 12 (ATCC No. HB 8551), F 3 (ATCC No. HB 8217), and K 21 (ATCC No. HB 8549).

    摘要翻译： 本发明描述了一种确定个体的分泌状态的方法，其包括从个体获得生物流体的样品，并确定样品是否包含Lewisa或Lewisb抗原，样本中Lewisa抗原的存在表明 个体是不分泌者，样本中Lewisb抗原的存在表明个体是分泌体，并且不存在表示个体分泌体状态的抗原是不确定的。 本发明还提供了一种进一步确定具有不确定分泌状态的个体的分泌状态的方法，其包括确定来自个体的生物流体样品是否包含A，B或前体1型链抗原，任何此类抗原存在于 样本表明个体是分泌体，样本中缺少任何这样的抗原，表明个体是非分泌者。 本发明提供了一种确定人类雌性受试者是否易于感染泌尿生殖器感染的方法，其包括根据上述方法确定受试者是否是分泌器，分泌器对这种感染敏感。 本申请还提供了一种从正常组织中分离尿路上皮癌的方法，并将人类生殖细胞肿瘤鉴定为精原细胞瘤或非神经瘤。 最后，本发明提供了包含部分或全部单克隆抗体H29-36（ATCC No.BB8248），S8（ATCC No.HB9036），T174（ATCC No.BB8242），T1818（ATCC No.BB8249），P12（ATCC No.HB8551），F3（ATCC No.HB8217）和K21（ATCC No.HB8549）。